GSK plc (GSK) - Cash Flow Conversion Efficiency
Based on the latest financial reports, GSK plc (GSK) has a cash flow conversion efficiency ratio of 0.147x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX2.53 Billion ≈ $307.34K USD) by net assets (GBX17.18 Billion ≈ $2.09 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see GSK plc stock valuation for the company's overall valuation and market capitalisation.
GSK plc - Cash Flow Conversion Efficiency Trend (1991–2025)
This chart illustrates how GSK plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View GSK plc share price for real-time trading data and today's change.
GSK plc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of GSK plc ranked by their cash flow conversion efficiency. Review GSK plc (GSK) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Osisko Gold Group Inc.
NYSE:OGG
|
0.002x |
|
ShuYu Civilian Pharmacy Corp. Ltd.
SHE:301017
|
N/A |
|
MBK Public Company Limited
BK:MBK
|
0.059x |
|
Liaoning Oxiranchem Inc
SHE:300082
|
-0.012x |
|
Joeone Co Ltd
SHG:601566
|
0.013x |
|
Shenzhen Sunshine Laser & Electronics Technology Co Ltd
SHE:300227
|
-0.059x |
|
Zhejiang Jingxing Paper Joint Stock Co Ltd
SHE:002067
|
0.019x |
|
Bata India Limited
NSE:BATAINDIA
|
0.166x |
Annual Cash Flow Conversion Efficiency for GSK plc (1991–2025)
The table below shows the annual cash flow conversion efficiency of GSK plc from 1991 to 2025. Also see GSK plc (GSK) total assets for a full breakdown of the balance sheet.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | GBX15.96 Billion ≈ $1.94 Million |
GBX7.30 Billion ≈ $888.56K |
0.458x | -8.61% |
| 2024-12-31 | GBX13.09 Billion ≈ $1.59 Million |
GBX6.55 Billion ≈ $797.43K |
0.501x | -5.32% |
| 2023-12-31 | GBX12.79 Billion ≈ $1.56 Million |
GBX6.77 Billion ≈ $823.47K |
0.529x | -27.86% |
| 2022-12-31 | GBX10.10 Billion ≈ $1.23 Million |
GBX7.40 Billion ≈ $900.73K |
0.733x | +96.80% |
| 2021-12-31 | GBX21.34 Billion ≈ $2.60 Million |
GBX7.95 Billion ≈ $967.53K |
0.373x | -8.15% |
| 2020-12-31 | GBX20.81 Billion ≈ $2.53 Million |
GBX8.44 Billion ≈ $1.03 Million |
0.406x | -7.15% |
| 2019-12-31 | GBX18.36 Billion ≈ $2.23 Million |
GBX8.02 Billion ≈ $975.80K |
0.437x | -80.95% |
| 2018-12-31 | GBX3.67 Billion ≈ $446.78K |
GBX8.42 Billion ≈ $1.02 Million |
2.293x | +15.66% |
| 2017-12-31 | GBX3.49 Billion ≈ $424.51K |
GBX6.92 Billion ≈ $841.72K |
1.983x | +51.46% |
| 2016-12-31 | GBX4.96 Billion ≈ $603.85K |
GBX6.50 Billion ≈ $790.50K |
1.309x | +352.40% |
| 2015-12-31 | GBX8.88 Billion ≈ $1.08 Million |
GBX2.57 Billion ≈ $312.57K |
0.289x | -72.41% |
| 2014-12-31 | GBX4.94 Billion ≈ $600.57K |
GBX5.18 Billion ≈ $629.77K |
1.049x | +13.43% |
| 2013-12-31 | GBX7.81 Billion ≈ $950.49K |
GBX7.22 Billion ≈ $878.71K |
0.924x | +42.36% |
| 2012-12-31 | GBX6.74 Billion ≈ $819.70K |
GBX4.38 Billion ≈ $532.31K |
0.649x | -8.28% |
| 2011-12-31 | GBX8.83 Billion ≈ $1.07 Million |
GBX6.25 Billion ≈ $760.44K |
0.708x | +1.52% |
| 2010-12-31 | GBX9.74 Billion ≈ $1.19 Million |
GBX6.80 Billion ≈ $827.00K |
0.697x | -4.45% |
| 2009-12-31 | GBX10.74 Billion ≈ $1.31 Million |
GBX7.84 Billion ≈ $954.02K |
0.730x | -16.95% |
| 2008-12-31 | GBX8.32 Billion ≈ $1.01 Million |
GBX7.31 Billion ≈ $889.54K |
0.879x | +50.44% |
| 2007-12-31 | GBX9.92 Billion ≈ $1.21 Million |
GBX5.79 Billion ≈ $705.08K |
0.584x | +42.36% |
| 2006-12-31 | GBX9.64 Billion ≈ $1.17 Million |
GBX3.96 Billion ≈ $481.57K |
0.410x | -44.41% |
| 2005-12-31 | GBX7.57 Billion ≈ $920.86K |
GBX5.59 Billion ≈ $679.78K |
0.738x | -4.80% |
| 2004-12-31 | GBX6.15 Billion ≈ $748.02K |
GBX4.77 Billion ≈ $580.01K |
0.775x | +35.11% |
| 2003-12-31 | GBX8.45 Billion ≈ $1.03 Million |
GBX4.85 Billion ≈ $590.33K |
0.574x | +38.56% |
| 2002-12-31 | GBX7.39 Billion ≈ $898.91K |
GBX3.06 Billion ≈ $372.31K |
0.414x | -24.54% |
| 2001-12-31 | GBX8.40 Billion ≈ $1.02 Million |
GBX4.61 Billion ≈ $560.79K |
0.549x | +165.41% |
| 2000-12-31 | GBX8.96 Billion ≈ $1.09 Million |
GBX1.85 Billion ≈ $225.33K |
0.207x | +29.48% |
| 1999-12-31 | GBX3.19 Billion ≈ $388.50K |
GBX510.00 Million ≈ $62.05K |
0.160x | +7.83% |
| 1998-12-31 | GBX2.77 Billion ≈ $336.79K |
GBX410.00 Million ≈ $49.89K |
0.148x | -54.48% |
| 1997-12-31 | GBX1.89 Billion ≈ $229.96K |
GBX615.00 Million ≈ $74.83K |
0.325x | -51.44% |
| 1996-12-31 | GBX1.27 Billion ≈ $154.16K |
GBX849.00 Million ≈ $103.30K |
0.670x | -88.17% |
| 1995-12-31 | GBX221.00 Million ≈ $26.89K |
GBX1.25 Billion ≈ $152.33K |
5.665x | +32.94% |
| 1995-06-30 | GBX574.69 Million ≈ $69.92K |
GBX2.45 Billion ≈ $297.98K |
4.261x | +1983.79% |
| 1994-06-30 | GBX5.15 Billion ≈ $626.48K |
GBX1.05 Billion ≈ $128.12K |
0.205x | +2.74% |
| 1993-06-30 | GBX4.66 Billion ≈ $566.62K |
GBX927.00 Million ≈ $112.79K |
0.199x | +10.25% |
| 1992-06-30 | GBX3.64 Billion ≈ $442.76K |
GBX657.00 Million ≈ $79.94K |
0.181x | -3.65% |
| 1991-06-30 | GBX3.28 Billion ≈ $399.32K |
GBX615.00 Million ≈ $74.83K |
0.187x | -- |
About GSK plc
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, infl… Read more